Cleared Traditional

K160334 - Advanced Medical Imaging Software Suite (KSWVWR)

K160334 is an FDA 510(k) clearance for Advanced Medical Imaging Software Suite..., manufactured by Keosys Sas. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 134-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jun 2016
Decision
134d
Days
Class 2
Risk

K160334 is an FDA 510(k) clearance for the Advanced Medical Imaging Software Suite (KSWVWR). Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Keosys Sas (Saint Herblain, FR). The FDA issued a Cleared decision on June 21, 2016 after a review of 134 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

FDA 510(k) Submission Details - K160334

510(k) Number K160334 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 08, 2016
Decision Date June 21, 2016
Days to Decision 134 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
27d slower than avg
Panel avg: 107d · This submission: 134d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 2229
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K160334.
hipEOS
K161479 · Onefit Medical · Jun 2016
Kuvia3D
K161559 · 4qimaging, LLC Dba Qmetrics · Jun 2016
IMPAX Volume Viewing 4.0
K161061 · Agfa Healthcare N.V. · Jun 2016
DBSWIN and VistaEasy Imaging Software
K161444 · Duerr Dental AG · Jun 2016
Quantib Brain 1
K153351 · Quantib B.V. · Jun 2016
HEPATIQ 1.1
K161188 · Hepatiq, LLC · Jun 2016